Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
SKT961
Skin tumor tissue array, set 1, non-overlapping with SKT962, 96 cores, 48 cases from normal, premalignant and cancer tissues with progressive grades and stages in duplicates
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$298
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification : Malignant melanoma of skin
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evicence of primary tumor
Tis - Melanoma in situ (Clark level I), (atypical melanocytic hyperplasia, severe melanocytic dysplasia, not an invasive malignant lesion)
T1 - Tumor 0.75 mm or less in thickness and invades the papillary dermis (Clark level II)
T2 - Tumor more than 0.75 mm but not more than 1.5 mm in thickness and or invades to the papillary-reticular dermis interface (Clark level III)
T3 Tumor more than 1.5 mm but not more than 4.0 mm in the thickness, and/or invades the reticular dermis (Clark level IV)
T3a - Tumor more than 1.5 mm but not more than 3.0 mm in thickness
T3b - Tumor more than 3.0 mm but not more than 4.0 mm in thickness
T4 - Tumor more than 4.0 mm in thickness, and/or invades subcutanesous tissue (Clark level V) and/or satellite(s) within 2 cm of the primary tumor
T4a - Tumor more than 4.0 mm in thickness and/or invades subcutanesous tissue
T4b - Satellite(s) within 2 cm of the primary tumor
Notes: in case of discrepancy between tumor thickness and level, the T category is based on the less favorable finding.
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed NO - No regional lymph node metastasis
N1 - Metastasis 3 cm or less in greatest dimension in any regional lymph node(s)
N2 - Metastasis more than 3 cm in greatest dimension in any regional lymph node(s) and/or in-transit metastasis
N2a - Metastasis more than 3 cm in greatest dimension in any regional lymph node(s)
N2b - In-transit metastasis
N2c - Both
M - Distant metastasis
MX - Distant metastasis cannot be assessed MO - No distant metastasis
M1 - Distant metastasis
M1a - Metastasis in skin or subcutaneous tissue or lymph node(s) beyond the regional lymph nodes
M1b - Visceral metastasis
Human
48
96
1.5mm
4um
8
12
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in evolution and progression of skin tumors.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | M | 53 | Skin, penis | Normal skin | |||
A02 | F | 15 | Skin, leg | Normal skin | |||
A03 | M | 57 | Skin, wrist | Chronic ulcer | |||
A04 | M | 1 | Head and neck, ear | Skin polyp | |||
A05 | F | 20 | Skin, vulva | Condyloma acuminata (HPV+) | |||
A06 | M | 17 | Skin, penis | Condyloma acuminata acuminatum | |||
A07 | M | 25 | Skin | Granuloma | |||
A08 | M | 10M | Skin | Hemangioma | |||
A09 | M | 22 | Subcutaneous tissue | Neurofibroma | |||
A10 | F | 44 | Subcutaneous tissue | Neurofibroma | |||
A11 | F | 24 | Scalp, subcutaneous tissue | Neurofibroma | |||
A12 | F | 67 | Subcutaneous tissue | Fibroma | |||
B01 | M | 53 | Skin, penis | Normal skin | |||
B02 | F | 15 | Skin, leg | Normal skin | |||
B03 | M | 57 | Skin, wrist | Chronic ulcer | |||
B04 | M | 1 | Head and neck, ear | Skin polyp | |||
B05 | F | 20 | Skin, vulva | Condyloma acuminata (HPV+) | |||
B06 | M | 17 | Skin, penis | Condyloma acuminata acuminatum | |||
B07 | M | 25 | Skin | Granuloma | |||
B08 | M | 10M | Skin | Hemangioma | |||
B09 | M | 22 | Subcutaneous tissue | Neurofibroma | |||
B10 | F | 44 | Subcutaneous tissue | Neurofibroma | |||
B11 | F | 24 | Scalp, subcutaneous tissue | Neurofibroma | |||
B12 | F | 67 | Subcutaneous tissue | Fibroma | |||
C01 | M | 50 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
C02 | M | 59 | Skin, face | Squamous cell carcinoma | I | T1N0M0 | |
C03 | M | 67 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
C04 | M | 40 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
C05 | F | 62 | Skin | Squamous cell carcinoma | I | T1N0M0 | |
C06 | F | 50 | Skin, leg | Squamous cell carcinoma | I | T2N0M0 | |
C07 | M | 34 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
C08 | M | 79 | Skin | Squamous cell carcinoma | I | T2N0M0 | |
C09 | F | 53 | Skin, head | Squamous cell carcinoma | I | T1N0M0 | |
C10 | M | 47 | Skin, penis | Squamous cell carcinoma | I | T1N1M0 | |
C11 | M | 40 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
C12 | M | 71 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
D01 | M | 50 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
D02 | M | 59 | Skin, face | Squamous cell carcinoma | I | T1N0M0 | |
D03 | M | 67 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
D04 | M | 40 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
D05 | F | 62 | Skin | Squamous cell carcinoma | I | T1N0M0 | |
D06 | F | 50 | Skin, leg | Squamous cell carcinoma | I | T2N0M0 | |
D07 | M | 34 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
D08 | M | 79 | Skin | Squamous cell carcinoma | I | T2N0M0 | |
D09 | F | 53 | Skin, head | Squamous cell carcinoma | I | T1N0M0 | |
D10 | M | 47 | Skin, penis | Squamous cell carcinoma | I | T1N1M0 | |
D11 | M | 40 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
D12 | M | 71 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
E01 | M | 57 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
E02 | M | 61 | Skin, head | Squamous cell carcinoma | II | T1N0M0 | |
E03 | M | 78 | Skin, face | Squamous cell carcinoma | II | T1N0M0 | |
E04 | M | 53 | Skin, trunk | Squamous cell carcinoma | II | T1N0M0 | |
E05 | M | 67 | Skin, trunk | Squamous cell carcinoma | II | T2N0M0 | |
E06 | F | 65 | Skin, vulva | Squamous cell carcinoma | II | T1N0M0 | |
E07 | M | 36 | Skin, head | Squamous cell carcinoma | II | T1N0M0 | |
E08 | M | 72 | Skin, head | Squamous cell carcinoma | III | T2N0M0 | |
E09 | M | 62 | Skin, leg | Basal cell carcinoma | T1N0M0 | ||
E10 | M | 89 | Skin, face | Basal cell carcinoma | T1N0M0 | ||
E11 | M | 80 | Skin, face | Basal cell carcinoma | T1N0M0 | ||
E12 | F | 35 | Scalp, subcutaneous tissue | Neuroendocrine carcinoma | T2N0M0 | ||
F01 | M | 57 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
F02 | M | 61 | Skin, head | Squamous cell carcinoma | II | T1N0M0 | |
F03 | M | 78 | Skin, face | Squamous cell carcinoma | II | T1N0M0 | |
F04 | M | 53 | Skin, trunk | Squamous cell carcinoma | II | T1N0M0 | |
F05 | M | 67 | Skin, trunk | Squamous cell carcinoma | II | T2N0M0 | |
F06 | F | 65 | Skin, vulva | Squamous cell carcinoma | II | T1N0M0 | |
F07 | M | 36 | Skin, head | Squamous cell carcinoma | II | T1N0M0 | |
F08 | M | 72 | Skin, head | Squamous cell carcinoma | III | T2N0M0 | |
F09 | M | 62 | Skin, leg | Basal cell carcinoma | T1N0M0 | ||
F10 | M | 89 | Skin, face | Basal cell carcinoma | T1N0M0 | ||
F11 | M | 80 | Skin, face | Basal cell carcinoma | T1N0M0 | ||
F12 | F | 35 | Scalp, subcutaneous tissue | Neuroendocrine carcinoma | T2N0M0 | ||
G01 | M | 62 | Lymph node, inguinal | Metastatic melanoma | |||
G02 | M | 64 | Skin, chest | Melanoma | |||
G03 | M | 60 | Skin, foot | Melanoma | |||
G04 | F | 64 | Scalp, subcutaneous tissue | Plasmacytoma | |||
G05 | F | 53 | Face, subcutaneous tissue | Fibrosarcoma? | |||
G06 | M | 44 | Chest wall, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
G07 | M | 45 | Scalp, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
G08 | F | 64 | Skin, leg, subcutaneous tissue | Malignant fibrous histiocytoma | |||
G09 | F | 41 | Trunk, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
G10 | F | 69 | Skin, neck, dermis, subcutaneous tissue | Metastatic squamous cell carcinoma of unknown site | |||
G11 | M | 56 | Skin, vulva, subcutaneous tissue | Metastatic adenocarcinoma | |||
G12 | F | 81 | Chest wall, dermis, subcutaneous tissue | Metastatic breast carcinoma | |||
H01 | M | 62 | Lymph node, inguinal | Metastatic melanoma | |||
H02 | M | 64 | Skin, chest | Melanoma | |||
H03 | M | 60 | Skin, foot | Melanoma | |||
H04 | F | 64 | Scalp, subcutaneous tissue | Plasmacytoma | |||
H05 | F | 53 | Face, subcutaneous tissue | Fibrosarcoma? | |||
H06 | M | 44 | Chest wall, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
H07 | M | 45 | Scalp, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
H08 | F | 64 | Skin, leg, subcutaneous tissue | Malignant fibrous histiocytoma | |||
H09 | F | 41 | Trunk, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
H10 | F | 69 | Skin, neck, dermis, subcutaneous tissue | Metastatic squamous cell carcinoma of unknown site | |||
H11 | M | 56 | Skin, vulva, subcutaneous tissue | Metastatic adenocarcinoma | |||
H12 | F | 81 | Chest wall, dermis, subcutaneous tissue | Metastatic breast carcinoma | |||
null |
